Back to search

Infliximab for refractory ulcerative colitis

Data up to Jan 2025

Published2001
Citations138
References16

Total Citations Per Year

Abstract

References (16)

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 • 3,152 citations

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 • 2,656 citations

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

1994 • 1,694 citations

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

1995 • 1,103 citations

Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety

1999 • 459 citations

Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis

1997 • 254 citations

Specific antibody response to oligomannosidic epitopes in Crohn's disease

1996 • 238 citations

Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type Responses

1999 • 177 citations

Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

1990 • 177 citations

Association of Antineutrophil Cytoplasmic Antibodies With Resistance to Treatment of Left-Sided Ulcerative Colitis: Results of a Pilot Study

1996 • 139 citations

Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571

1997 • 133 citations

Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients.

1995 • 113 citations

Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

1997 • 97 citations

Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease

1996 • 83 citations

The Effect of Dietary Yeast on the Activity of Stable Chronic Crohn's Disease

1992 • 76 citations

Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis

1997 • 58 citations

Cited By (0)

Loading...
Infliximab for refractory ulcerative colitis (2001) – The American Journal of Gastroenterology | Metascience Observatory Explorer